Remibrutinib in Real-world Clinical Practice - a US Sub-study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Remibrutinib in Real-world Clinical Practice - a US Sub-study — Stella

Recruiting

Back to Chronic Spontaneous Urticaria trials

Trial locations(1 site)

United States

Cleaver Dermatology, Kirksville, Missouri

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~505 participants

Started

February 2026

Primary completion

September 2029

Age range

18 Years – 100 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov